Which medication is known as a Short Acting Insulin?

Humalog is classified as a short-acting insulin, specifically designed to quickly lower blood glucose levels. This type of insulin starts to work within 15 minutes after injection and can effectively control blood sugar spikes that occur after meals. It mimics the natural insulin response to food intake, making it particularly useful for managing blood glucose levels in people with diabetes.

In contrast, Lantus is a long-acting insulin, providing a steady release of insulin over an extended period, usually 24 hours. Salmeterol is a long-acting beta-agonist used for asthma and chronic obstructive pulmonary disease (COPD), and it has no relevance to insulin therapy. Digoxin is a medication used to treat heart conditions, particularly atrial fibrillation and heart failure, and is not related to insulin or blood glucose control. Thus, Humalog is the appropriate choice as it plays a direct role in the management of blood glucose levels in individuals requiring short-acting insulin.